ScopeUniversitätsklinikum Essen Institut für Transfusionsmedizin, Transplantationsdiagnostik
31 capabilities
Accredited since February 2026
Verified Apr 2026
One of 3,039 in Germany
Details
Virchowstraße 179
Essen 45147 , Germany
Essen 45147 , Germany
Accreditation
Active
DAkkS
D-ML-18383-06-01
Offers immunological and microbiological testing with primary focus on membrane antigen identification through flow cytometry in blood samples, and functional cellular testing including cytokine release measurement.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-18383-06-01
Status
ActiveSince
25 February 2026
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (31)
| Standard Reference | Description | Category |
|---|---|---|
| Clostridium tetani AK | Clostridium tetani-AK | Biocompatibility (ISO 10993) |
| HLA Typisierung | Serologische HLA Typisierung | Biocompatibility (ISO 10993) |
| HLA-Klasse I und II) | HLA-Klasse I und II) | Biocompatibility (ISO 10993) |
| Lymphozyten Transformationstest | Lymphozytentransformationstest | Biocompatibility (ISO 10993) |
| Thrombozyten-spezifische | Thrombozyten-spezifische | Biocompatibility (ISO 10993) |
| Corynebacterium diphtheriae-AK | Corynebacterium diphtheriae-AK | Clinical Microbiology |
| Stimulation mit Antigenen | Stimulation mit Antigenen | Food Safety Testing |
| Serologische Verträglichkeitsprüfung | Serologische Verträglichkeitsprüfung | Hematology |
| (BKV ELISpot) | (BKV ELISpot) | Immunology / Serology |
| (CMV ELISpot) | (CMV ELISpot) | Immunology / Serology |
| (EBV ELISpot) | (EBV ELISpot) | Immunology / Serology |
| (Mitogene) | (Mitogene) | Immunology / Serology |
| (VZV ELISpot) | (VZV ELISpot) | Immunology / Serology |
| Antikörper (HPA-AK) | Antikörper (HPA-AK) | Immunology / Serology |
| CoV-2 (SARS-CoV-2 ELISpot) | CoV-2 (SARS-CoV-2 ELISpot) | Immunology / Serology |
| Durchflusszytometrische | durchflusszytometrische | Immunology / Serology |
| Freisetzung von IFN-γ nach | Freisetzung von IFN-γ nach | Immunology / Serology |
| HLA spezifische Antikörper | HLA spezifische Antikörper | Immunology / Serology |
| HLA-Antikörper (Crossmatch) | HLA-Antikörper (Crossmatch) | Immunology / Serology |
| HLA-System (Crossmatch) | HLA-System (Crossmatch) | Immunology / Serology |
| Membranständige Antigene | Membranständige Antigene | Immunology / Serology |
| Chimärismus-Analyse nach | Chimärismus-Analyse nach | Molecular Diagnostics / PCR |
| HLA Typisierung und HLA-Loss | HLA Typisierung und HLA-Loss | Molecular Diagnostics / PCR |
| Stammzell-Transplantation | Stammzell-Transplantation | Molecular Diagnostics / PCR |
| (Sequenzspezifische | (Sequenzspezifische | Other |
| (Thrombozyten-serologische | (Thrombozyten-serologische | Other |
| CD4, CD8, CD14, CD16/56, CD45) | CD4, CD8, CD14, CD16/56, CD45) | Other |
| Klasse I) | Klasse I) | Other |
| Oligonukleotide) | Oligonukleotide) | Other |
| Untersuchung | [OMIM#160900] (Untersuchung | Other |
| tuberculosis -Komplex (TB | tuberculosis -Komplex (TB | Other |